Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2

Na Zhou(Tianjin Medical University General Hospital), Yi Zhang(Beijing Research Institute of Mechanical and Electrical Technology)

Cell Death Discovery

October 29, 2021

10.1038/s41420-021-00728-1

Cited by 11

Related Papers

Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells

|Stem Cell Research & Therapy|2021|86

Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation

|Human Cell|2023|15

Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2

|Research Square|2020|0